|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mariette C, Piessen G and Triboulet JP:
Therapeutic strategies in oesophageal carcinoma: Role of surgery
and other modalities. Lancet Oncol. 8:545–553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chu Y, Zhu H, Lv L, Zhou Y and Huo J:
MiRNA s in oesophageal squamous cancer. Neth J Med. 71:69–75.
2013.PubMed/NCBI
|
|
7
|
Wang C, Wang X, Su Z, Fei H, Liu X and Pan
Q: MiR-25 promotes hepatocellular carcinoma cell growth, migration
and invasion by inhibiting RhoGDI1. Oncotarget. 6:36231–36244.
2015.PubMed/NCBI
|
|
8
|
Wu T, Chen W, Kong D, Li X, Lu H, Liu S,
Wang J, Du L, Kong Q, Huang X, et al: miR-25 targets the modulator
of apoptosis 1 gene in lung cancer. Carcinogenesis. 36:925–935.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zoni E, van der Horst G, van de Merbel AF,
Chen L, Rane JK, Pelger RC, Collins AT, Visakorpi T, Snaar-Jagalska
BE, Maitland NJ, et al: miR-25 modulates invasiveness and
dissemination of human prostate cancer cells via regulation of
αv- and α6-integrin expression. Cancer Res.
75:2326–2336. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li BS, Zuo QF, Zhao YL, Xiao B, Zhuang Y,
Mao XH, Wu C, Yang SM, Zeng H, Zou QM, et al: MicroRNA-25 promotes
gastric cancer migration, invasion and proliferation by directly
targeting transducer of ERBB2, 1 and correlates with poor survival.
Oncogene. 34:2556–2565. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Komatsu S, Ichikawa D, Hirajima S,
Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Arita T, Konishi H,
Shiozaki A, et al: Plasma microRNA profiles: Identification of
miR-25 as a novel diagnostic and monitoring biomarker in
oesophageal squamous cell carcinoma. Br J Cancer. 111:1614–1624.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang WK, Liao LD, Li LY, Xie YM, Xu XE,
Zhao WJ, Wu JY, Zhu MX, Wu ZY, Du ZP, et al: Down-regulated
desmocollin-2 promotes cell aggressiveness through redistributing
adherens junctions and activating beta-catenin signalling in
oesophageal squamous cell carcinoma. J Pathol. 231:257–270. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiang J, Hang JB, Che JM and Li HC: MiR-25
is up-regulated in non-small cell lung cancer and promotes cell
proliferation and motility by targeting FBXW7. Int J Clin Exp
Pathol. 8:9147–9153. 2015.PubMed/NCBI
|
|
14
|
Lu D, Davis MP, Abreu-Goodger C, Wang W,
Campos LS, Siede J, Vigorito E, Skarnes WC, Dunham I, Enright AJ,
et al: MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming
of mouse fibroblast cells to iPSCs. PLoS One. 7:e409382012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gong J, Cui Z, Li L, Ma Q, Wang Q, Gao Y
and Sun H: MicroRNA-25 promotes gastric cancer proliferation,
invasion, and migration by directly targeting F-box and WD-40
domain protein 7, FBXW7. Tumour Biol. 36:7831–7840. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Ye X, Liu Y, Wei W and Wang Z:
Aberrant regulation of FBW7 in cancer. Oncotarget. 5:2000–2015.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao QY and Fang JY: Early esophageal
cancer screening in China. Best Pract Res Clin Gastroenterol.
29:885–893. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kong KL, Kwong DL, Chan TH, Law SY, Chen
L, Li Y, Qin YR and Guan XY: MicroRNA-375 inhibits tumour growth
and metastasis in oesophageal squamous cell carcinoma through
repressing insulin-like growth factor 1 receptor. Gut. 61:33–42.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ren LH, Chen WX, Li S, He XY, Zhang ZM, Li
M, Cao RS, Hao B, Zhang HJ, Qiu HQ, et al: MicroRNA-183 promotes
proliferation and invasion in oesophageal squamous cell carcinoma
by targeting programmed cell death 4. Br J Cancer. 111:2003–2013.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X,
Zhang Y, Chen X, Wang J, Zen K, et al: Diagnostic and prognostic
implications of a serum miRNA panel in oesophageal squamous cell
carcinoma. PLoS One. 9:e922922014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao J, Ge MH and Ling ZQ: Fbxw7 tumor
suppressor: A vital regulator contributes to human tumorigenesis.
Medicine. 95:e24962016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakayama KI and Nakayama K: Ubiquitin
ligases: Cell-cycle control and cancer. Nat Rev Cancer. 6:369–381.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mao JH, Kim IJ, Wu D, Climent J, Kang HC,
DelRosario R and Balmain A: FBXW7 targets mTOR for degradation and
cooperates with PTEN in tumor suppression. Science. 321:1499–1502.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Welcker M and Clurman BE: FBW7 ubiquitin
ligase: A tumour suppressor at the crossroads of cell division,
growth and differentiation. Nat Rev Cancer. 8:83–93. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Inuzuka H, Shaik S, Onoyama I, Gao D,
Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, et al:
SCFFBW7 regulates cellular apoptosis by targeting MCL1
for ubiquitylation and destruction. Nature. 471:104–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wertz IE, Kusam S, Lam C, Okamoto T,
Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu J, et al:
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1
and FBW7. Nature. 471:110–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Perez-Losada J, Mao JH and Balmain A:
Control of genomic instability and epithelial tumor development by
the p53-Fbxw7/Cdc4 pathway. Cancer Res. 65:6488–6492. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kurashige J, Watanabe M, Iwatsuki M,
Kinoshita K, Saito S, Hiyoshi Y, Kamohara H, Baba Y, Mimori K and
Baba H: Overexpression of microRNA-223 regulates the ubiquitin
ligase FBXW7 in oesophageal squamous cell carcinoma. Br J Cancer.
106:182–188. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang M, Wang X, Li W and Cui Y: miR-107
and miR-25 simultaneously target LATS2 and regulate proliferation
and invasion of gastric adenocarcinoma (GAC) cells. Biochem Biophys
Res Commun. 460:806–812. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang T, Chen T, Li Y, Gao L, Zhang S, Wang
T and Chen M: Downregulation of miR-25 modulates non-small cell
lung cancer cells by targeting CDC42. Tumour Biol. 36:1903–1911.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He Z, Liu Y, Xiao B and Qian X: miR-25
modulates NSCLC cell radio-sensitivity through directly inhibiting
BTG2 expression. Biochem Biophys Res Commun. 457:235–241. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peter ME: Targeting of mRNAs by multiple
miRNAs: The next step. Oncogene. 29:2161–2164. 2010. View Article : Google Scholar : PubMed/NCBI
|
